PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · World J Nucl Med 2020; 19(04): 398-403
DOI: 10.4103/wjnm.WJNM_61_19
Original Article

Detection of muscle metastases on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan in 13 cases

Abderrahim Doudouh
1   Department of Nuclear Medicine, Military Hospital Mohammed V, Rabat, Morocco
2   Department of Biophysics, Faculty of Medicine and Pharmacy, UM5, Rabat, Morocco
,
Salah Oueriagli
1   Department of Nuclear Medicine, Military Hospital Mohammed V, Rabat, Morocco
,
Jaafar Bakkali
1   Department of Nuclear Medicine, Military Hospital Mohammed V, Rabat, Morocco
› Author Affiliations
› Further Information
Also available ateRefMedOne
  Permissions and Reprints
Preview

Abstract

Muscular metastases (MMs) form an infrequent entity, and their physiopathology is still not well-defined. In this study, we estimated the incidence of MMs that were detected by 18F-fluorodeoxyglucose positron emission tomography/computed tomography and also specified their metabolic characteristics. This study includes 13 patients with MMs from a remotely located primary tumor. The results of this study showed an incidence of MMs at about 1%, with the most frequently involved muscles being iliopsoas and paraspinal. Lung cancer seems to be the most common tumor that causes MMs. Furthermore, these MMs vary in size and physiological uptake; they seem to be out of the ordinary and easily detected. They are often associated with other extra muscular locations and frequently involve the trunk muscles. Their detection in the course of the evolution of a specific neoplasia testifies to their aggressiveness and portends an unfavorable prognosis. The data in our series confirm that in the literature regarding the underlying primary tumors and anatomical sites involved by MMs.

Keywords

18F-fluorodeoxyglucose - iliopsoas - muscular metastases - neoplasia - paraspinal - physiological uptakes - positron emission tomography/computed tomography

Financial support and sponsorship

Nil.




Publication History

Received: 17 September 2019

Accepted: 06 November 2019

Article published online:
19 April 2022

© 2020. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ferrandina G, Salutari V, Testa A, Zannoni GF, Petrillo M, Scambia G, et al. Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: A case report and review of the literature. BMC Cancer 2006;6:169.
  • 2 So Y, Yi JG, Song I, Lee WW, Chung HW, Park JH, et al. Detection of skeletal muscle metastasis: Torso FDG PET-CT versus contrast-enhanced chest or abdomen CT. Acta Radiol 2015;56:860-6.
  • 3 Haygood TM, Wong J, Lin JC, Li S, Matamoros A, Costelloe CM, et al. Skeletal muscle metastases: A three-part study of a not-so-rare entity. Skeletal Radiol 2012;41:899-909.
  • 4 Sudo A, Ogihara Y, Shiokawa Y, Fujinami S, Sekiguchi S. Intramuscular metastasis of carcinoma. Clin Orthop Relat Res 1993;296:213-7.
  • 5 Surov A, Köhler J, Wienke A, Gufler H, Bach AG, Schramm D, et al. Muscle metastases: Comparison of features in different primary tumours. Cancer Imaging 2014;14:21.
  • 6 Faure E, Le Pimpec-Barthes F, Dusser D, Riquet M. Skeletal muscle metastases from non small cell lung. Rev Mal Respir 2002;19:93-5.
  • 7 Menard O, Seigneur J, Lamy P. Muscular metastasis of primary bronchial carcinoma. Rev Pneumol Clin 1990;46:183-6.
  • 8 Magee T, Rosenthal H. Skeletal muscle metastases at sites of documented trauma. AJR Am J Roentgenol 2002;178:985-8.
  • 9 Mathis S, Fromont-Hankard G, du Boisguéheneuc F, Godenèche G, Mahieu F, Balaboi I, et al. Muscular metastasis. Rev Neurol (Paris) 2010;166:295-304.
  • 10 Williams JB, Youngberg RA, Bui-Mansfield LT, Pitcher JD. MR imaging of skeletal muscle metastases. AJR Am J Roentgenol 1997;168:555-7.
  • 11 de la Fouchardière C, Desseigne F, Orlandini F, de la Fouchardière A, Négrier S. Cardiac metastases and colorectal cancer: A case study. Gastroenterol Clin Biol 2007;31:621-3.
  • 12 Cornily JC, Pennec PY, Blanc JJ. Malignant tumors of the heart and the pericardium. Lett Cardiol 2009;42:26-9.
  • 13 Bouzouitaa A, Ben Slamaa MR, Mohameda MO, Larbia H, Selmia S, Cherifa M, et al. Cardiac metastasis of renal cell carcinoma, a rare location. Progrès Urol 2011;21:492-4.
  • 14 Cornily JC, Pennec PY, Castellant P, Bezon E, Le Gal G, Gilard M, et al. Cardiac tamponade in medical patients: A 10-year follow-up survey. Cardiology 2008;111:197-201.
  • 15 Parida GK, Roy SG, Kumar R. FDG-PET/CT in skeletal muscle: Pitfalls and pathologies. Semin Nucl Med 2017;47:362-72.
  • 16 Surov A, Hainz M, Holzhausen HJ, Arnold D, Katzer M, Schmidt J, et al. Skeletal muscle metastases: Primary tumours, prevalence, and radiological features. Eur Radiol 2010;20:649-58.
  • 17 Park SM, Lee IS, Song YS, Park SY, Lee H , Yi JH, et al. Soft tissue metastasis in patients with primary malignancies; magnetic resonance imaging and clinical evaluations. J Korean Soc Radiol 2018;78:321-9.
  • 18 Lee BY, Choi JE, Park JM, Jee WH, Kim JY, Lee KH, et al. Various image findings of skeletal muscle metastases with clinical correlation. Skeletal Radiol 2008;37:923-8.
  • 19 Hlavatá Z, Pazderová N, Povinec P, Paulíny P, Majidi A, Fiala P, et al. The value of 18-FDG PET/CT imaging in a patient with atypical metastatic colorectal cancer – Case report: 18-FDG PET/CT in colorectal cancer. Klin Onkol 2009;22:284-7.
  • 20 Kwas HH, Zendah I, Ghedira H. Skeletal muscle metastases from lung cancer. Asian Cardiovasc Thorac Ann 2013;21:741-3.
  • 21 Banzo I, Martínez-Rodriguez I, Quirce R, Jimenez-Bonilla J, Carril JM. Asymptomatic muscle metastasis from pulmonary adenocarcinoma. Thorax 2011;66:642.
  • 22 Emmering J, Vogel WV, Stokkel MP. Intramuscular metastases on FDG PET-CT: A review of the literature. Nucl Med Commun 2012;33:117-20.
  • 23 Basu S, Mahajan A. Psoas muscle metastasis from cervical carcinoma: Correlation and comparison of diagnostic features on FDG-PET/CT and diffusion-weighted MRI. World J Radiol 2014;6:125-9.
  • 24 Bello-Roufai D, Soares DG, Kerrou K, Khalil A, Richard S, Gligorov J, et al. Long-term complete response in a breast cancer patient with skeletal muscle metastases diagnosed using 18F-FDG-PET. Oxf Med Case Reports 2017;2017:omx002. https://doi.org/10.1093/omcr/omx002.
  • 25 Savas K, Pinar KZ, Sevda KS, Ugur K, Evrim S, Halit C, et al. Haematogenous muscular metastasis of non-small cell lung cancer in F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Contemp Oncol (Pozn) 2015;19:241-5.
  • 26 San Roman J, Hovsepian M. Unsuspected muscle metastases detected with 18F-FDG PET/CT. Rev Argent Radiol 2017;81:12-6.
  • 27 Karyağar S, Kesici U, Karyağar S, Kece C, Güner A, Duman G, et al. Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT. Turk J Gastroenterol 2015;26:195-6.
  • 28 Maréchal E, Rivat P, Leclercq R. An unusual shoulder stiffness: metastasis in the infraspinatus muscle as the first clinical manifestation of lung carcinoma. Rev Chir Orthop Reparatrice Appar Mot 2001;87:79-83.
  • 29 Di Giorgio A, Sammartino P, Cardini CL, Al Mansour M, Accarpio F, Sibio S, et al. Lung cancer and skeletal muscle metastases. Ann Thorac Surg 2004;78:709-11.